Viatris Inc. (VTRS) 今日盘前股价大幅上涨5.27%，表现亮眼。
消息面上，公司公布的第一季度业绩超出市场预期，营收和利润均超分析师预估。这主要得益于其在中国市场的强劲表现以及品牌药品（如立普妥、诺瓦斯克）销售的旺盛需求。此外，公司高管在近期电话会议中透露，对2026年大中华区业务发展持乐观态度，预计该市场营收将实现中高个位数增长，进一步增强了市场信心。
公司不仅重申了2026年的盈利和营收预测，其在中国及多个新兴市场的增长也超出了预期，展现了公司核心业务的稳定性与增长潜力。这些积极因素共同推动了股价在盘前交易时段的大幅上扬。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.